东欧和中亚公众疫苗信心状况调查
2023年6至7月在六个东欧和中亚国家对每国1000名公众用疫苗信心指数调查对疫苗安全性、重要性、有效性及与个人信念兼容性的信心,总体疫苗信心平均43.7%,低于2022年欧盟27国平均49.97%,结论认为需更多研究了解疫苗信心水平、驱动因素与趋势。
要点
- 六国总体疫苗信心平均43.7%,低于2022年欧盟27国平均49.97%。
- 一般疫苗信心最低为哈萨克斯坦35.5%,最高为格鲁吉亚51.8%。
- 特定疫苗信心及信心各维度贡献在各国间和国内差异很大。
核心结论
- 东欧和中亚国家疫苗信心证据有限,需更多研究以更好了解疫苗信心水平、驱动因素和时间趋势,从而帮助制定针对性干预措施以提高对现有和新型疫苗的信心与接种意愿。
研究设计与样本
- 2023年6月至7月在北马其顿、波斯尼亚和黑塞哥维那、白俄罗斯、亚美尼亚、格鲁吉亚和哈萨克斯坦对公众进行横断面调查,每国n=1000,使用疫苗信心指数(VCI)测量对疫苗安全性、重要性、有效性及与个人信念兼容性的信心。
- 评估对一般疫苗以及麻疹-腮腺炎-风疹(MMR)、人乳头瘤病毒(HPV)、季节性流感(flu)和Covid-19疫苗的信心水平。
- 采用双变量逻辑回归探讨各国社会人口学特征与疫苗信心之间的关系。
主要发现
- 六国总体疫苗信心平均为43.7%,低于2022年欧盟27国平均49.97%。
- 一般疫苗信心最低为哈萨克斯坦35.5%,最高为格鲁吉亚51.8%。
- 特定疫苗的信心在研究国家间差异很大,信心各维度(感知重要性、安全性、有效性和与宗教信仰的兼容性)的水平及其在各国间和国内对信心形成的贡献也不同。
- 社会人口学变量与疫苗信心的关系因国家而异,凸显疫苗信心的复杂性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic brought global attention to challenges vaccination programs face in relation to public confidence and exposed important differences in vaccine acceptance worldwide-prompting renewed emphasis on monitoring of vaccine confidence. Most studies in Europe focus on the 27 European Union (EU) countries, with sparse evidence among the broader WHO European Region. This study extend coverage of vaccine confidence surveillance where such research is limited. METHODS: Members of the general public in North Macedonia, Bosnia and Herzegovina, Belarus, Armenia, Georgia, and Kazakhstan were surveyed between June and July of 2023 (n = 1000 per country) using the Vaccine Confidence Index (VCI) to measure confidence in the safety, importance, effectiveness of vaccines and their compatibility with personal beliefs. Levels of vaccine confidence for vaccines in general as well as for the measles-mumps-rubella (MMR), Human Papillomavirus (HPV), seasonal influenza (flu), and Covid-19 vaccine were assessed. Bi-variate logistic regressions explore the relationship between socio-demographic characteristics and vaccine confidence in each country. RESULTS: Across the 6 countries, the average for overall vaccine confidence was 43.7 %, lower than the 2022 EU-27 average of 49.97 %. Confidence in vaccines in general was lowest in Kazakhstan (35.5 %) and highest in Georgia (51.8 %). Confidence in specific vaccines varied greatly between the study countries, as did the levels of each dimension of confidence (perceived importance, safety, effectiveness, and compatibility with religious beliefs) and how they contributed to shaping confidence between and within each country. Relationships between socio-demographic variables were country-specific, highlighting the complexity of vaccine confidence. CONCLUSION: With limited vaccine confidence evidence in Eastern European and Central Asian countries, more research is needed to better understand vaccine confidence levels, drivers, and trends over time. This could help inform tailored interventions to improve confidence and acceptance of existing and new vaccines.
引用
- Eagan RL, Claessens T, Hendrickx G, et al. The state of vaccine confidence among the general public in Eastern Europe and Central Asia. Vaccine. 2025. PMID: 41129883. doi:10.1016/j.vaccine.2025.127849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。